Merck KGaA

News

Pfizer/Merck KGaA eye fast review for kidney cancer combo

A combination therapy based around Pfizer and Merck KGaA’s Bavencio has outperformed standard of care in a late-stage trial in untreated but advanced kidney cancer.

Views & Analysis

Curious2018: A thirst for innovation

All too often pharma companies are accused of putting shareholders before their patients and society as a whole.

Sales & Marketing

J&J tops the pharma market cap charts – but for how long?

Data and analytics firm GlobalData has tracked the market cap and performance of the top 25 pharma companies for the first quarter of this year – and there are some notable changes compared

News

P&G buys Merck KGaA's consumer health unit for $4.2bn

Merck KGaA is to sell its consumer health business to Procter and Gamble for $4.2 billion, continuing the trend for big pharma companies to rethink their investment in over-the-counter prod

News